Back to top
more

BioSpecifics Technologies Corp (BSTC)

(Delayed Data from NSDQ)

$66.72 USD

66.72
62,398

+0.21 (0.32%)

Updated May 3, 2019 04:00 PM ET

After-Market: $66.90 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

BioSpecifics Technologies (BSTC) Surpasses Q3 Earnings and Revenue Estimates

BioSpecifics (BSTC) delivered earnings and revenue surprises of 315.79% and 106.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: BioSpecifics Technologies (BSTC) Q3 Earnings Expected to Decline

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endo (ENDP) Q3 Earnings & Sales Top Estimates, View Raised

Endo's (ENDP) earnings and sales beat estimates in the third quarter. The company raises its annual outlook.

Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates

The biotech sector was in focus as Biogen's (BIIB) Q3 results disappoint, Vertex (VRTX) stops study and Regeneron's (REGN) Ebola drug gets FDA approval.

Endo (ENDP) Gains on Deal to Acquire BioSpecifics for $540M

Endo (ENDP) gains from the acquisition of commercial-stage biopharmaceutical company, BioSpecifics Technologies Corp.

The Truth About Market Timing - October 06, 2020

In the long-run, does consistent market timing really matter to be a successful investor?

The Keys to Successfully Timing the Markets - August 18, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

New Strong Sell Stocks for August 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Catalyst's (CPRX) Q2 Earnings & Revenues Beat Estimates

Catalyst (CPRX) beats both earnings and sales estimates in the second quarter of 2020.

BioSpecifics Technologies (BSTC) Surpasses Q2 Earnings and Revenue Estimates

BioSpecifics (BSTC) delivered earnings and revenue surprises of 320.00% and 89.47%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate BioSpecifics Technologies (BSTC) to Report a Decline in Earnings: What to Look Out for

BioSpecifics (BSTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

When Does Market Timing Actually Work? - July 29, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

IMV Catches Eye: Stock Jumps 10%

IMV saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

Cassava Sciences (SAVA) Jumps: Stock Rises 9.2%

Cassava Sciences (SAVA) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Timing the Market, Is it Possible? - July 07, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

The Truth About Market Timing - June 17, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

Zacks.com featured highlights include: BioSpecificsTechnologies, eXp World, Elbit Systems and KoninklijkeVopak

Zacks.com featured highlights include: BioSpecificsTechnologies, eXp World, Elbit Systems and KoninklijkeVopak

Moumita C. Chattopadhyay headshot

4 Stocks With Rising Cash Flows to Beat Coronavirus Crisis

Cash is the lifeblood of any business, and provides vitality and strength to a company.

Is BioSpecifics Technologies (BSTC) Stock Outpacing Its Medical Peers This Year?

Is (BSTC) Outperforming Other Medical Stocks This Year?

Timing the Market, Is it Possible? - April 28, 2020

Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?

Tirthankar Chakraborty headshot

New Strong Buy Stocks for April 23rd

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Zacks.com featured highlights include: PJT Partners, CBIZ, BioSpecifics Technologies, eXp World and Gibraltar Industries

Zacks.com featured highlights include: PJT Partners, CBIZ, BioSpecifics Technologies, eXp World and Gibraltar Industries

Moumita C. Chattopadhyay headshot

5 Stocks With Rising Cash Flows to Battle Coronavirus Crisis

Cash provides vitality and strength to a company. It holds the key to the company's existence, development and success, and can indeed be referred to as its lifeblood.

Zacks.com featured highlights include: Gibraltar Industries, CBIZ, Integer, BioSpecifics Technologies and DHT

Zacks.com featured highlights include: Gibraltar Industries, CBIZ, Integer, BioSpecifics Technologies and DHT